Brief: Zhongzhi Pharmaceutical Holdings Says FY Profit Attributable RMB114.7 Mln
25/03/2020 15:28
March 25 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
3737.HK :
* RECOMMENDING A FINAL DIVIDEND OF HK2.9 CENTS PER SHARE AND
A
SPECIAL DIVIDEND OF HK1.45 CENTS PER SHARE
* FY REVENUE RMB1.34 BILLION VERSUS RMB1.14 BILLION
* FY PROFIT ATTRIBUTABLE RMB114.7 MILLION VERSUS RMB85.1
MILLION
Source text for Eikon: ID:nHKS5rRL6W
Further company coverage: 3737.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhongzhi Pharmaceutical Holdings
See all newsBrief: Zhongzhi Pharmaceutical Expects Over 70% Decrease In 2025 Net Profit
Brief: Zhongzhi Pharmaceutical Expects 90% Decrease In HY Net Profit
Brief: Zhongzhi Pharmaceutical Posts HY Profit Attributable RMB83.4 Million
Brief: Zhongzhi Pharmaceutical Sees Decrease In Net Profit Of 40% For HY
Brief: Zhongzhi Pharmaceutical Declares Final Dividend Of HK3 Cents Per Share